Blue Shield of California
COVID-19 Resource Center for Employers, Plan Sponsors, Brokers and Consultants

B2B General

October 06, 2021 - 4 min read

Four things to know: COVID-19 developments

Mandates for employers, vaccines for kids, and more


As the pandemic continues, several key developments are once again shaping the landscape for American businesses, their employees, and their communities. Here we cover four changes to COVID-19 policies, the effects of those changes, and we look ahead at what’s to come.

Note: content here is current as of October 2021. We will continue to update this page with relevant information as it becomes available.

1. Vaccine mandates for employers

We know the focus for many employers is on vaccine and testing requirements. Occupational Safety and Health Administration (OSHA), the agency in charge of enforcing the mandate announced by Biden in early September, has not released further guidance. To the best of our knowledge, the vaccine and testing requirements are awaiting review from the Office of Management and Budget – the last step before a federal rule is released.

As a reminder, the federal mandate requiring COVID-19 diagnostic testing to be a covered benefit (at no cost to the member) applies only when the test is provided or ordered by a healthcare provider; testing for employment purposes or general surveillance is not included in this requirement.

2. Pfizer booster shots approved

In late September, the CDC authorized booster shots for recipients of the Pfizer vaccine. Aimed at protecting frontline workers and those at higher risk due to medical conditions, booster shots will be available to persons who received their second dose at least six months ago and who meet other eligibility rules. Californians who qualify may schedule their “third dose” appointment through the State’s My Turn website. It is not yet known when Moderna or Johnson & Johnson vaccine recipients will be eligible for booster shots.

3. Pfizer vaccine shown effective in kids aged 5-11

Using data based on antibody response – opposed to infections and hospitalizations – Pfizer announced their vaccine is safe and effective for children aged 5-11 years. A lower dose of the vaccine will be used in this age group (10 mcg vs. 30 mcg for those 12 and older) and an FDA decision on the shot’s Emergency Use Authorization (EUA) for the age groups is expected in October.

4. Relaxed travel restrictions for vaccinated travelers to the U.S

Fully vaccinated air travelers from a list of 33 countries will be allowed entry into the U.S. beginning this November. The list of countries includes China, Brazil, India, and most European countries. Foreign nationals and American citizens returning to the U.S will be required to take a COVID-19 test within three days of their flight, providing proof of the negative result before boarding their flight.

Our COVID-19 resources page has additional information and resources, and our News Center is your source for COVID-19 and other health-related articles. Subscribe to our News Center to have updates delivered straight to your inbox.

Latest articles

article - October 01, 2021 - 3 min read

Back to school with COVID-19 [UPDATED]

article - September 16, 2021 - 4 min read

The growth and digital future of mental health care in the workplace

How telemedicine and online solutions are supporting mental health

article - July 15, 2021 - 3 min read

The delta variant of COVID-19 spreads, putting the unvaccinated at risk

The variant has quickly become the dominant strain of coronavirus in the country